
Gwen Lomberk, PhD
Chief, Division of Research; Director, Basic Science Research; Department of Surgery; Professor of Surgery and Pharmacology & Toxicology
Contact Information
Education
Research Interests
Publications
-
Priming therapy by targeting enhancer-initiated pathways in patient-derived pancreatic cancer cells.
(Fraunhoffer NA, Moreno Vega AI, Abuelafia AM, Morvan M, Lebarbier E, Mary-Huard T, Zimmermann MT, Lomberk G, Urrutia R, Dusetti N, Blum Y, Nicolle R, Iovanna J.) EBioMedicine. 2023 Jun;92:104602 PMID: 37148583 PMCID: PMC10189188 SCOPUS ID: 2-s2.0-85154565512 05/06/2023
-
(Yang Y, Bhargava D, Chen X, Zhou T, Dursuk G, Jiang W, Wang J, Zong Z, Katz SI, Lomberk GA, Urrutia RA, Katz JP.) Cell Death Dis. 2023 May 02;14(5):299 PMID: 37130837 PMCID: PMC10154356 SCOPUS ID: 2-s2.0-85157983058 05/03/2023
-
(Ratnasinghe BD, Haque N, Wagenknecht JB, Jensen DR, Esparza GV, Leverence EN, De Assuncao TM, Mathison AJ, Lomberk G, Smith BC, Volkman BF, Urrutia R, Zimmermann MT.) bioRxiv. 2023 Apr 28 PMID: 37207265 PMCID: PMC10189839 05/19/2023
-
G9a Modulates Lipid Metabolism in CD4 T Cells to Regulate Intestinal Inflammation.
(Ramos GP, Bamidele AO, Klatt EE, Sagstetter MR, Kurdi AT, Hamdan FH, Kosinsky RL, Gaballa JM, Nair A, Sun Z, Dasari S, Lanza IR, Rozeveld CN, Schott MB, Urrutia G, Westphal MS, Clarkson BD, Howe CL, Marietta EV, Luckey DH, Murray JA, Gonzalez M, Braga Neto MB, Gibbons HR, Smyrk TC, Johnsen S, Lomberk G, Faubion WA.) Gastroenterology. 2023 Feb;164(2):256-271.e10 PMID: 36272457 PMCID: PMC9892272 SCOPUS ID: 2-s2.0-85146286897 10/23/2022
-
Priming therapy by targeting enhancer-initiated pathways in patient-derived pancreatic cancer cells
(Fraunhoffer NA, Moreno Vega AI, Abuelafia AM, Morvan M, Lebarbier E, Mary-Huard T, Zimmermann M, Lomberk G, Urrutia R, Dusetti N, Blum Y, Nicolle R, Iovanna J.) eBioMedicine. June 2023;92 SCOPUS ID: 2-s2.0-85154565512 06/01/2023
-
(Fraunhoffer NA, Abuelafia AM, Bigonnet M, Gayet O, Roques J, Nicolle R, Lomberk G, Urrutia R, Dusetti N, Iovanna J.) NPJ Precis Oncol. 2022 Aug 17;6(1):57 PMID: 35978026 PMCID: PMC9385633 08/18/2022
-
NUPR1 protects against hyperPARylation-dependent cell death.
(Santofimia-Castaño P, Huang C, Liu X, Xia Y, Audebert S, Camoin L, Peng L, Lomberk G, Urrutia R, Soubeyran P, Neira JL, Iovanna J.) Commun Biol. 2022 Jul 22;5(1):732 PMID: 35869257 PMCID: PMC9307593 SCOPUS ID: 2-s2.0-85134559984 07/23/2022
-
(Urrutia G, Abrudan JL, Du M, de Assuncao TM, Mathison AJ, Zimmermann MT, Lomberk G, Urrutia R.) FASEB J. 2022 May;36 Suppl 1 PMID: 35556470 SCOPUS ID: 2-s2.0-85130072518 05/14/2022
-
(Urrutia R, Salmonson A, Urrutia G, de Assuncao TM, Zimmermann MT, Mathison AJ, Lomberk G.) FASEB J. 2022 May;36 Suppl 1 PMID: 35556469 SCOPUS ID: 2-s2.0-85130010001 05/14/2022
-
(Fraunhoffer NA, Abuelafia AM, Bigonnet M, Gayet O, Roques J, Nicolle R, Lomberk G, Urrutia R, Dusetti N, Iovanna J.) npj Precision Oncology. December 2022;6(1) SCOPUS ID: 2-s2.0-85136999952 12/01/2022
-
Precision medicine in trauma: a transformational frontier in patient care, education, and research
(Davis CS, Wilkinson KH, Lin E, Carpenter NJ, Georgeades C, Lomberk G, Urrutia R.) European Journal of Trauma and Emergency Surgery. August 2022;48(4):2607-2612 SCOPUS ID: 2-s2.0-85119154805 08/01/2022
-
(Chi YI, Stodola TJ, De Assuncao TM, Leverence EN, Smith BC, Volkman BF, Mathison AJ, Lomberk G, Zimmermann MT, Urrutia R.) Comput Struct Biotechnol J. 2022;20:2200-2211 PMID: 35615018 PMCID: PMC9111933 SCOPUS ID: 2-s2.0-85130080827 05/27/2022